Literature DB >> 25721210

Infiltration of dendritic cells and T lymphocytes predicts favorable outcome in epithelial ovarian cancer.

Z Zhang1, J Huang2, C Zhang3, H Yang1, H Qiu1, J Li1, Y Liu1, L Qin1, L Wang1, S Hao1, F Zhang4, X Wang5, B Shan3.   

Abstract

We aimed to analyze the association between the distribution of dendritic cells (DC) with expression of tumor-infiltrating T lymphocytes and clinicopathologic parameters with prognosis in epithelial ovarian cancer (EOC). Thirty-three EOC patient samples were surgically resected, and pathology was examined for clinicopathological variables. Expression of S-100, CD1a, CD45RA and CD45RO was detected using the avidin-biotin complex immunohistochemical technique. The correlation of protein expression with surgical and pathological stage, histological grade, pathological type and prognosis was analyzed. There was significant difference in the CD45RA positive rate in early- and advanced-stage EOC with 50 and 10.5%, respectively (P<0.05). Univariate analysis showed that CD45RO, histological grade and surgical-pathological staging were all factors that influenced the prognosis of patients with EOC. Higher survival rates were found in patients with harboring populations of CD1a(+) DC and CD45RO(+) T lymphocytes or populations of S-100(+) DC and CD45RO(+) T lymphocytes (P<0.05). In addition, histological grade is related to cumulative survival rate. The higher degree of cell differentiation presented better outcome. In conclusion, EOC patients with populations of DC and CD45RO(+) T lymphocytes had a higher survival rate. Histological grade and surgical-pathological stage were independent factors affecting prognosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25721210     DOI: 10.1038/cgt.2015.7

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  15 in total

1.  Prognostic value of CD83-positive mature dendritic cells and their relation to vascular endothelial growth factor in advanced human gastric cancer.

Authors:  Shoichi Tsukayama; Kenji Omura; Koichi Yoshida; Yoko Tanaka; Go Watanabe
Journal:  Oncol Rep       Date:  2005-08       Impact factor: 3.906

2.  An immunohistochemical study of CD1a and CD83-positive infiltrating dendritic cell density in cervical neoplasia.

Authors:  Abdul Rahman Hayati; Mohammad Zulkarnaen
Journal:  Int J Gynecol Pathol       Date:  2007-01       Impact factor: 2.762

3.  [Expression of S-100 positive dendritic cell, TIMP-1 and p63 and its significance in the primary laryngeal carcinoma].

Authors:  Pin Dong; Xiaoyan Li; Zhenghua Zhu; Ziwei Yu; Guangzhong Lu; Zhenfeng Sun; Sang Wang
Journal:  Lin Chuang Er Bi Yan Hou Ke Za Zhi       Date:  2005-02

4.  Dendritic cell infiltration and prognosis of human hepatocellular carcinoma.

Authors:  Xiao-Yan Cai; Qiang Gao; Shuang-Jian Qiu; Sheng-Long Ye; Zhi-Quan Wu; Jia Fan; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-19       Impact factor: 4.553

5.  Infiltrating dendritic/Langerhans cells in primary breast cancer.

Authors:  T Tsuge; M Yamakawa; M Tsukamoto
Journal:  Breast Cancer Res Treat       Date:  2000-01       Impact factor: 4.872

6.  [Tumor infiltrating dendritic cells in relation to prognosis of lung cancer].

Authors:  X Gong; Y Yan; J Wu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2000-03

7.  Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo.

Authors:  S McBreen; S Imlach; T Shirafuji; G R Scott; C Leen; J E Bell; P Simmonds
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.

Authors:  Mitsuhiko Iwamoto; Hisashi Shinohara; Akiko Miyamoto; Masaaki Okuzawa; Hideaki Mabuchi; Takehiro Nohara; Goki Gon; Masao Toyoda; Nobuhiko Tanigawa
Journal:  Int J Cancer       Date:  2003-03-10       Impact factor: 7.396

9.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

10.  [Alternation and significance of CD4(+)CD45RA(+) and CD4(+)CD45RO(+) T cells in peripheral blood of colorectal cancer patients].

Authors:  Gang Xiao; Gang Zhao; Xiao-dong Xu; Jing-hai Song; Mei-xiong Huang; Jun-min Wei
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2003-07
View more
  15 in total

Review 1.  Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application.

Authors:  Masaki Mandai; Junzo Hamanishi; Kaoru Abiko; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2016-03-11       Impact factor: 3.402

Review 2.  Beyond direct killing-novel cellular immunotherapeutic strategies to reshape the tumor microenvironment.

Authors:  Duc Huynh; Pia Winter; Florian Märkl; Stefan Endres; Sebastian Kobold
Journal:  Semin Immunopathol       Date:  2022-09-27       Impact factor: 11.759

Review 3.  Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.

Authors:  Marta Szajnik; Małgorzata Czystowska-Kuźmicz; Esther Elishaev; Theresa L Whiteside
Journal:  Expert Rev Mol Diagn       Date:  2016-06-23       Impact factor: 5.225

4.  Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high-grade serous ovarian cancer.

Authors:  Guodong Zhang; Qing Xu; Xiangyun Zhang; Moran Yang; Yiying Wang; Mengdi He; Jiaqi Lu; Haiou Liu
Journal:  Cancer Med       Date:  2021-05-05       Impact factor: 4.452

Review 5.  Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine.

Authors:  Jeanne Galaine; Christophe Borg; Yann Godet; Olivier Adotévi
Journal:  Vaccines (Basel)       Date:  2015-06-30

Review 6.  The role of immune checkpoint inhibition in the treatment of ovarian cancer.

Authors:  Stéphanie L Gaillard; Angeles A Secord; Bradley Monk
Journal:  Gynecol Oncol Res Pract       Date:  2016-11-24

7.  Tumor-infiltrating CD45RO+ Memory T Lymphocytes Predict Favorable Clinical Outcome in Solid Tumors.

Authors:  Guoming Hu; Shimin Wang
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

8.  Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer.

Authors:  X Yan; S-C Jiao; G-Q Zhang; Y Guan; J-L Wang
Journal:  Cancer Gene Ther       Date:  2017-01-13       Impact factor: 5.987

Review 9.  Role of tumor microenvironment in ovarian cancer pathobiology.

Authors:  Alia Ghoneum; Hesham Afify; Ziyan Salih; Michael Kelly; Neveen Said
Journal:  Oncotarget       Date:  2018-04-27

10.  Inflammation and tumor progression: signaling pathways and targeted intervention.

Authors:  Huakan Zhao; Lei Wu; Guifang Yan; Yu Chen; Mingyue Zhou; Yongzhong Wu; Yongsheng Li
Journal:  Signal Transduct Target Ther       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.